Quantcast
Home » Topics » Transcept Pharmaceuticals

U.S. approves drug for middle-of-the-night insomniacs

The US Food and Drug Administration, for the first time, approved Wednesday medication specifically designed for those who wake up in the middle of the night and cannot fall back to sleep. Intermezzo, manufactured by Transcept Pharmaceuticals of California, is a lower-dose formulation of zolpidem, first approved in the United States in…

Google+